Imiti ya Hypoglycemic

CAT # Izina ryibicuruzwa Ibisobanuro
CPD0004 Ertugliflozin E.
CPDA0048 Omarigliptin Omarigliptin, izwi kandi ku izina rya MK-3102, ni imbaraga zikomeye kandi zimara igihe kirekire DPP-4 inhibitori yo kuvura rimwe mu cyumweru kuvura diyabete yo mu bwoko bwa 2.
CPDA1089 Retagliptin Retagliptin, izwi kandi ku izina rya SP-2086, ni DPP-4 inhibitor ishobora gukoreshwa mu kuvura diyabete yo mu bwoko bwa 2.
CPDA0088 Trelagliptin Trelagliptin, izwi kandi ku izina rya SYR-472, ni inzitizi ndende ya dipeptidyl peptidase-4 (DPP-4) inhibitor ikorwa na Takeda mu rwego rwo kuvura diyabete yo mu bwoko bwa 2 (T2D).
CPDA2039 Linagliptin Linagliptin, izwi kandi ku izina rya BI-1356, ni inhibitor ya DPP-4 yakozwe na Boehringer Ingelheim mu kuvura diyabete yo mu bwoko bwa II.
CPDA0100 Sitagliptin Sitagliptin (INN; mbere yiswe MK-0431 ikagurishwa ku izina ry'ubucuruzi Januvia) ni imiti igabanya ubukana bwo mu kanwa (imiti irwanya diyabete) yo mu cyiciro cya inhibitori ya dipeptidyl peptidase-4 (DPP-4).
CPD0854 LX-4211 LX-4211 nimbaraga ebyiri SGLT2 / 1 inhibitor; Imiti igabanya ubukana.
CPDA1553 LX-2761 LX2761 ni inhibitor ya SGLT1 ikora cyane muri vitro kandi ikadindiza kwinjiza amara glucose muri vivo kugirango irusheho kurwanya glycemic.
Ese?

Twandikire

Itohoza

Amakuru agezweho

  • Inzira 7 Zambere Mubushakashatsi bwa Farumasi Muri 2018

    Inzira 7 Zambere Mubushakashatsi bwa Farumasi I ...

    Kuba uri munsi yigitutu cyinshi kugirango duhatane mubibazo bitoroshye byubukungu n’ikoranabuhanga, uruganda rukora imiti n’ibinyabuzima rugomba guhora rushya muri gahunda zabo za R&D kugirango rukomeze imbere ...

  • ARS-1620: Kanseri nshya ya KRAS-mutant

    ARS-1620: Inhibitor nshya itanga ikizere kuri K ...

    Nk’uko ubushakashatsi bwasohotse mu Kagari bubitangaza, abashakashatsi bakoze inzitizi yihariye ya KRASG12C yitwa ARS-1602 itera ibibyimba gusubira mu mbeba. "Ubu bushakashatsi butanga muri vivo ibimenyetso byerekana ko mutant KRAS ishobora kuba ...

  • AstraZeneca yakira imbaraga zo kugenzura imiti ya oncology

    AstraZeneca yakira imbaraga zo kugenzura ...

    Ku wa kabiri, AstraZeneca yakiriye inshuro ebyiri mu nshingano zayo za oncology, nyuma y’uko abagenzuzi b’Amerika n’Uburayi bemeye gutanga amabwiriza agenga imiti y’ibiyobyabwenge, intambwe yambere yo gutsindira kwemerwa niyi miti. ...

Ikiganiro cya WhatsApp Kumurongo!